| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.70B | 24.51B | 24.25B | 24.12B | 24.88B | 21.80B |
| Gross Profit | 11.28B | 14.55B | 11.04B | 10.53B | 11.21B | 10.51B |
| EBITDA | 12.98B | 12.95B | 12.50B | 11.93B | 12.64B | 11.84B |
| Net Income | 7.21B | 7.14B | 6.75B | 6.38B | 7.00B | 6.52B |
Balance Sheet | ||||||
| Total Assets | 69.64B | 69.70B | 67.72B | 67.13B | 65.45B | 63.52B |
| Cash, Cash Equivalents and Short-Term Investments | 1.04B | 1.52B | 1.04B | 1.07B | 1.02B | 1.01B |
| Total Debt | 31.50B | 31.81B | 32.46B | 34.18B | 34.96B | 31.49B |
| Total Liabilities | 50.23B | 51.23B | 50.83B | 52.34B | 53.29B | 49.36B |
| Stockholders Equity | 19.42B | 18.47B | 16.89B | 14.79B | 12.16B | 14.16B |
Cash Flow | ||||||
| Free Cash Flow | 5.70B | 5.50B | 5.89B | 4.77B | 5.74B | 6.10B |
| Operating Cash Flow | 9.52B | 9.29B | 9.35B | 8.38B | 9.36B | 9.03B |
| Investing Cash Flow | -3.81B | -3.76B | -3.33B | -3.67B | -3.47B | -2.71B |
| Financing Cash Flow | -6.38B | -5.28B | -6.07B | -4.63B | -5.89B | -7.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $83.30B | 23.65 | 23.52% | 1.42% | -0.92% | -2.64% | |
72 Outperform | C$93.37B | 19.09 | 21.93% | 2.62% | 0.47% | 6.34% | |
72 Outperform | C$104.48B | 29.01 | 8.85% | 0.82% | 1.10% | 8.73% | |
71 Outperform | $23.14B | 35.63 | 17.30% | 0.89% | 0.58% | 17.20% | |
71 Outperform | $70.08B | 29.53 | 17.43% | 1.85% | 0.60% | -19.01% | |
65 Neutral | $157.13B | 21.15 | 40.38% | 2.32% | 1.87% | 9.41% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |